12:00 AM
 | 
May 18, 2015
 |  BC Week In Review  |  Company News  |  Deals

AM-Pharma, Pfizer deal

Pfizer purchased a 17.5% equity stake in AM-Pharma and received an option acquire the remainder of the company. The option is exercisable...

Read the full 89 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >